BSG and myocardial infarction: In conclusion, we propose the use of Ivabradine as a mechanism to prevent the inflammatory signaling elicited in response to acute myocardial infarction by inhibiting the secretion and binding of CyPA to its receptor EMMPRIN, as a way to avoid extracellular matrix degradation and necrosis.